📊 Injective set for DeFi boost with Tria’s chain abstraction
Tria, the consumer-first modular chain abstraction platform, has expanded to the Injective blockchain network. INJ price was down 6% on Tuesday despite the positive development.
On July 30, the Tria team announced the introduction of Unchained on Injective.
Per the announcement, this integration will allow users to connect to any chain on Injective using any crypto asset. There will be no need for bridges, swaps or the requirement to pay gas, Tria revealed.
According to Injective Labs CEO Eric Chen, the integration means barriers and complexities that have burdened users will no longer matter.
This includes things like switching wallets, bridging or getting tokens for gas tokens. Tria’s ‘Unchained’ infrastructure will manage this, allowing users to enjoy the benefits of Web3.
🔸 Tria’s Unchained chain abstraction on Injective
Unchained offers a modular chain-abstraction Actively Validated Services layer 2 built on the Cosmos SDK.
The AVS L2 provides for EVM-compatible dual execution technology that makes it possible for users to interact with decentralised applications on multiple chains without shifting from the chain or UI they are using.
With Tria’s integration, users within the Injective ecosystem can now connect to any wallet, including Metamask and Phantom.
Users will also be able to use any asset on any chain, whether EVM compatible, Solana tokens or BTC without requiring bridges, swaps, or gas.
💬 Tria’s plug-and-play chain abstraction module will soon be available to all developers.
Here is an early look into how dApps across the Injective ecosystem are beginning to integrate the chain abstraction module into their products. — Tria
Also notable is that the integration sees Tria bring easy onboarding, unified assets and staking to the Injective ecosystem.
It’s a move that could greatly boost the DeFi market on Injective.
